WHO invites Covid vaccine manufacturers in late stage trials for emergency use listing

The World Health Organisation has made the first call inviting manufacturers of Covid-19 vaccine candidates in late phase 2 and phase 3 clinical trials to seek from it prequalification and/or emergency use listing (EUL) – a key criteria considered by various UN agencies as well as by countries globally while purchasing vaccine.